Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance
January 15, 2025 08:30 ET
|
Myriad Genetics, Inc.
Myriad Genetics announces select preliminary fourth quarter and full year 2024 financial results and introduces full year 2025 financial guidance.
Nutrigenomics Industry Sees $15.7 Billion Opportunity by 2034: Obesity Applications Dominate Revenues, Cancer Research Applications to Grow at the Highest CAGR
January 14, 2025 06:16 ET
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Nutrigenomics Market by Product, Application, Technique, End-User, and Region" report has been added to ResearchAndMarkets.com's offering. This...
Wellness Genomics Market Forecast Report 2024-2032: Lucrative Opportunities with Expansion into Emerging Markets, Partnerships, Digital Health Platforms Integration, and Preventive Health Programs
January 14, 2025 04:01 ET
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Wellness Genomics Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global wellness genomics market...
Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health Systems
January 13, 2025 10:00 ET
|
Baylor Genetics
Baylor Genetics announced its integration with Aura, the specialty diagnostics suite from leading electronic health record (EHR) company Epic.
Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History
January 09, 2025 16:30 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced it signed an agreement with sports broadcaster Hannah Storm to promote the importance of knowing family cancer history.
UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 11:27 ET
|
Myriad Genetics, Inc.
Paul J. Diaz, President and CEO, and Sam Raha, COO, Myriad Genetics, will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 08:00 ET
|
Myriad Genetics, Inc.
Paul J. Diaz, President and CEO, and Sam Raha, COO, Myriad Genetics, will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
January 07, 2025 08:00 ET
|
Myriad Genetics, Inc.
The University of Texas MD Anderson Cancer Center and Myriad Genetics announced a five-year strategic alliance.
Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report
January 06, 2025 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics released its Quality, Innovation, and Corporate Responsibility Report.
Genetic Testing Market Analysis with Forecasts Report 2025 with Executive and Consultant Guides, & Profiles of 140+ Companies
January 06, 2025 07:58 ET
|
Research and Markets
Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides"...